Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLPG0974 in mild to moderate ulcerative colitis
NCT01829321Phase 2Completed
- Sponsor
- Galapagos NV
- Start
- Apr 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of GLPG0974 in ulcerative colitis (UC), sponsored by Galapagos NV. Started Apr 2013; status: completed.
02
Drugs
GLPG0974
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01829321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829321.